Ethermed
PrivateLast Round
Series A
Apr 21, 2026
Total Funding Raised
$15M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Ethermed operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a Series A round in April 2026.
Ethermed is a healthcare technology company that provides an AI-powered SaaS platform to automate prior authorizations. The platform integrates with EHR and payer systems to streamline workflows, reduce administrative work, and accelerate patient access to treatment.
Sector
Healthcare & Life Sciences
Verticals
Workflow Automation, Revenue Cycle, EHR & EMR, Medical AI, NLP & Conversational AI
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ethermed Comparables
Compare Ethermed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Humata Health | 88% | |
| Ascertain | 85% | |
| Silna Health | 85% |
For institutional investors. Book with your work email.
Ethermed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 21, 2026 | ||||
| Seed | Mar 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ethermed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Enfield Capital Partners | Series A |
| JumpStart Ventures | Series A |
| Gaingels | Series A, Seed |
| Woodard Investments | Series A |
| Healthliant Ventures | Series A |
| Blue Marlin Partners | Series A |
| Woodard & Company Asset Management Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2026
Grew 17% QoQ, from 29 to 34 employees.
- Apr 26, 2026
Grew 15% QoQ, from 26 to 30 employees.
For institutional investors. Book with your work email.
Ethermed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ethermed's valuation, stock price, and market status.
Is Ethermed a public or private company?
Ethermed is a private company.
What is the current stock price of Ethermed?
Ethermed is a private company, so its shares have no public market price. Caplight tracks Ethermed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ethermed worth (valuation)?
Valuation information for Ethermed is not publicly available.
Can I buy Ethermed stock?
Ethermed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ethermed's last funding round?
Ethermed's most recent funding round was Series A on April 21, 2026.
Who are the main investors in Ethermed?
Key investors in Ethermed include Enfield Capital Partners, Blue Marlin Partners.
Will Ethermed IPO soon?
No public IPO plans have been announced for Ethermed.
How can I track Ethermed secondary market activity?
Caplight tracks bids, offers, and trades in Ethermed's shares on secondary markets.